Health Care: Drugs

United Therapeutics Corp (UTHR: NASDAQ)

$102.11 n/a | n/a%
06/24/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 102.11
52 Week High 181.03
52 Week Low 101.03
Avg. Daily Vol. (Mil) 0.72
Beta (3 year) 1.55
Share Related Items
Mkt Cap (Mil) 4,556.35
Shares Out (Mil) 44.62
Float (Mil) 37.09
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.30
Current Ratio 3.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 5.60
Price/Sales 3.02
Price/Book 2.66
Price/Cash Flow 4.80
Per Share Data
Earnings 18.14
Sales 33.78
Book Value 38.36
Cash Flow 21.10
Business Summary
United Therapeutics Corp is a biotechnology company. The Company is engaged in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions.
General Information
1040 Spring Street
Silver Spring, MD 20910
www.unither.com
Industry : Drugs
Sector: Health Care
Employees: 750
CEO: Martine A. Rothblatt,PhD
Short Interest
Current Month (Mil) 8.72
Previous Month (Mil) 8.64
Short Interest Ratio (Days) 16.00
Management Effectiveness
Return on Equity 52.80
Return on Assets 41.20
Return on Investments 52.80
Profitability
Gross Margin 99.30
EBIT Margin 94.80
Profit Margin 60.00

Portfolios with UTHR

Latest UTHR Headlines from TheStreet

More Financial News for UTHR

Press Releases for UTHR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter